Jakub Tomasik

1.2k total citations
35 papers, 828 citations indexed

About

Jakub Tomasik is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Jakub Tomasik has authored 35 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Biological Psychiatry, 12 papers in Psychiatry and Mental health and 9 papers in Molecular Biology. Recurrent topics in Jakub Tomasik's work include Tryptophan and brain disorders (17 papers), Bipolar Disorder and Treatment (9 papers) and Mental Health Treatment and Access (7 papers). Jakub Tomasik is often cited by papers focused on Tryptophan and brain disorders (17 papers), Bipolar Disorder and Treatment (9 papers) and Mental Health Treatment and Access (7 papers). Jakub Tomasik collaborates with scholars based in United Kingdom, Netherlands and Germany. Jakub Tomasik's co-authors include Sabine Bahn, Paul C. Guest, Hassan Rahmoune, Robert H. Yolken, Emanuel Schwarz, Faith Dickerson, René S. Kahn, Lot D. de Witte, Jason D. Cooper and Nitin Rustogi and has published in prestigious journals such as PLoS ONE, Science Advances and Progress in Neurobiology.

In The Last Decade

Jakub Tomasik

34 papers receiving 813 citations

Peers

Jakub Tomasik

PMH

PHYSI

Bartholomeus C. M. Haarman Netherlands

Lesley Cousins United Kingdom

Timothy R. Powell United Kingdom

Jan Aleksander Beszłej Poland

G. P. Kostyuk Russia

Sunee Sirivichayakul Thailand

Nico J.M. van Beveren Netherlands

Meihong Xiu China

Armin Birner Austria

Maiko Hayashida Japan

Bartholomeus C. M. Haarman Netherlands

Jakub Tomasik

426 ×0.9

196 ×0.7

379 ×1.6

PMH

149 ×1.1

131 ×1.3

PHYSI

Citations per year, relative to Jakub Tomasik Jakub Tomasik (= 1×) peers Bartholomeus C. M. Haarman

Countries citing papers authored by Jakub Tomasik

Since Specialization

Citations

This map shows the geographic impact of Jakub Tomasik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakub Tomasik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakub Tomasik more than expected).

Fields of papers citing papers by Jakub Tomasik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakub Tomasik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakub Tomasik. The network helps show where Jakub Tomasik may publish in the future.

Co-authorship network of co-authors of Jakub Tomasik

This figure shows the co-authorship network connecting the top 25 collaborators of Jakub Tomasik. A scholar is included among the top collaborators of Jakub Tomasik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakub Tomasik. Jakub Tomasik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tomasik, Jakub, et al.. (2025). IUPHAR review: Drug repurposing in Schizophrenia – An updated review of clinical trials. Pharmacological Research. 213. 107633–107633. 1 indexed citations

Martin-Key, Nayra A, et al.. (2025). Differential symptom relief profiles of menopausal therapies: an online survey study. BMC Women s Health. 25(1). 384–384. 1 indexed citations

Rustogi, Nitin, Shiral S. Gangadin, Hemmo A. Drexhage, et al.. (2024). Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia. Schizophrenia Research. 266. 66–74. 1 indexed citations

Tomasik, Jakub, et al.. (2024). Identification of Predictors of Mood Disorder Misdiagnosis and Subsequent Help-Seeking Behavior in Individuals With Depressive Symptoms: Gradient-Boosted Tree Machine Learning Approach. JMIR Mental Health. 11. e50738–e50738. 3 indexed citations

Tomasik, Jakub, Scott J. Harrison, Nitin Rustogi, et al.. (2023). Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression. JAMA Psychiatry. 81(1). 101–101. 20 indexed citations

Tomasik, Jakub, Nitin Rustogi, Javier Vázquez-Bourgón, et al.. (2022). Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naïve schizophrenia. Brain Behavior and Immunity. 103. 37–49. 9 indexed citations

Tomasik, Jakub, et al.. (2021). Functional patient-derived cellular models for neuropsychiatric drug discovery. Translational Psychiatry. 11(1). 128–128. 12 indexed citations

Martin-Key, Nayra A, Jason D. Cooper, Emily Bell, et al.. (2021). The Delta Study – Prevalence and characteristics of mood disorders in 924 individuals with low mood: Results of the of the World Health Organization Composite International Diagnostic Interview (CIDI). Brain and Behavior. 11(6). e02167–e02167. 6 indexed citations

Martin-Key, Nayra A, Jason D. Cooper, Emily Bell, et al.. (2021). Personality, symptom, and demographic correlates of perceived efficacy of selective serotonin reuptake inhibitor monotherapy among current users with low mood: A data-driven approach. Journal of Affective Disorders. 295. 1122–1130.

10.

Martin-Key, Nayra A, et al.. (2021). The Current State and Validity of Digital Assessment Tools for Psychiatry: Systematic Review. JMIR Mental Health. 9(3). e32824–e32824. 23 indexed citations

11.

Tomasik, Jakub, Nitin Rustogi, Julie Rask Larsen, et al.. (2020). Leptin Serum Levels are Associated With GLP-1 Receptor Agonist-Mediated Effects on Glucose Metabolism in Clozapine- or Olanzapine-Treated, Prediabetic, Schizophrenia Patients. Schizophrenia Bulletin Open. 1(1). 3 indexed citations

12.

Martin-Key, Nayra A, et al.. (2020). The Current State and Diagnostic Accuracy of Digital Mental Health Assessment Tools for Psychiatric Disorders: Protocol for a Systematic Review and Meta-analysis. JMIR Research Protocols. 10(1). e25382–e25382. 10 indexed citations

13.

Cooper, Jason D., Emily Bell, Süreyya Özcan, et al.. (2020). A Combined Digital and Biomarker Diagnostic Aid for Mood Disorders (the Delta Trial): Protocol for an Observational Study. JMIR Research Protocols. 9(8). e18453–e18453. 15 indexed citations

14.

Tomasik, Jakub, Nitin Rustogi, Jason D. Cooper, et al.. (2020). Diagnostic prediction model development using data from dried blood spot proteomics and a digital mental health assessment to identify major depressive disorder among individuals presenting with low mood. Brain Behavior and Immunity. 90. 184–195. 13 indexed citations

15.

Ham, Henk‐Jan van den, Jason D. Cooper, Jakub Tomasik, et al.. (2018). Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment. PLoS ONE. 13(2). e0192278–e0192278. 6 indexed citations

16.

Cox, David, Jakub Tomasik, Nitin Rustogi, et al.. (2017). Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patients. Brain Behavior and Immunity. 67. 364–373. 19 indexed citations

17.

Witte, Lot D. de, Jakub Tomasik, Emanuel Schwarz, et al.. (2014). Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophrenia Research. 154(1-3). 23–29. 152 indexed citations

18.

Chan, Man K., Michael G. Gottschalk, F. Haenisch, et al.. (2014). Applications of blood-based protein biomarker strategies in the study of psychiatric disorders. Progress in Neurobiology. 122. 45–72. 69 indexed citations

19.

Tomasik, Jakub, Hassan Rahmoune, Paul C. Guest, & Sabine Bahn. (2014). Neuroimmune biomarkers in schizophrenia. Schizophrenia Research. 176(1). 3–13. 123 indexed citations

20.

Guest, Paul C., Daniel Martins‐de‐Souza, Emanuel Schwarz, et al.. (2013). Proteomic profiling in schizophrenia: enabling stratification for more effective treatment. Genome Medicine. 5(3). 25–25. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact